Drug Type CAR-T |
Synonyms CD146/HER2 CAR-T cells(Essen Biotech) |
Target |
Action modulators |
Mechanism HER2 modulators(Receptor tyrosine-protein kinase erbB-2 modulators), Muc18 modulators(Melanoma cell adhesion molecule modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ewing Sarcoma | Phase 2 | China | 29 May 2025 | |
Kaposi Sarcoma | Phase 2 | China | 29 May 2025 | |
Lymphoma | Phase 2 | China | 29 May 2025 | |
Metastatic osteosarcoma | Phase 2 | China | 29 May 2025 | |
Soft Tissue Sarcoma | Phase 2 | China | 29 May 2025 | |
Synovial Sarcoma | Phase 2 | China | 29 May 2025 |